Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
4128019 | Annales de Pathologie | 2016 | 9 Pages |
Abstract
Loss of BAP1 expression is an indicator of MMD in a context of mesothelial proliferation. This immunohistochemistry could be integrated in the panel of immunostaining used for MMD diagnosis, either on histological or cytological samples. Furthermore, loss of BAP1 expression guides the patient to an oncology genetic counseling in order to eliminate a MMD developed as part of a constitutional genetic defect.
Related Topics
Health Sciences
Medicine and Dentistry
Pathology and Medical Technology
Authors
Alexandre Jaouen, Françoise Thivolet-Bejui, Lara Chalabreysse, Eric Piaton, Alexandra Traverse-Glehen, Sylvie Isaac, Myriam Decaussin-Petrucci, Laurianne Depaepe, Juliette Fontaine, Isabelle Remy, Jean-Michel Maury, Marie Brevet,